Viewing nowCombinationEmpagliflozin/Metformin Tablet 12.5/850 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.

MFDS item code 202302569 · Approved 2023.08.30 · Insurance code 698504910
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medicine is used as an adjunct to diet and exercise to help control blood sugar levels in adult patients with Type 2 diabetes. It is particularly suitable for patients whose blood sugar is not adequately controlled, and it works effectively by combining empagliflozin and metformin to manage blood sugar. Furthermore, patients with cardiovascular disease should follow expert guidelines regarding the occurrence of cardiovascular events when using this medication. Considering these factors, safe treatment can assist in blood sugar control.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should take their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with food to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in that case, skip the missed dose. No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be monitored carefully every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients Who Must Not Receive This Medicine, item 2)). In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.
This medication can cause a rare but serious side effect called lactic acidosis, so it should not be administered to patients at high risk of lactic acidosis. Caution is necessary when used with other diabetes medications due to the risk of hypoglycemia. This medication should not be used in patients with moderate to severe renal impairment or acute kidney issues. Administration should be discontinued during specific acute conditions such as acute infections, heart dysfunction, and before and after surgery. It is not safe for use during pregnancy or breastfeeding. As this medication affects kidney function, regular kidney function tests should be conducted, especially for elderly patients or those with impaired kidney function. Patients at risk of fluid loss may experience dehydration or hypotension, requiring careful observation. This medication may increase the risk of urinary and genital infections; symptoms should be reported to healthcare professionals immediately. During treatment, patients should be aware of symptoms of hypoglycemia, and dosage adjustments may be necessary if used in conjunction with insulin or other hypoglycemic agents. Regular blood tests are recommended as vitamin B12 levels may decrease. Alcohol consumption should be avoided as it can increase the risk of lactic acidosis. This medication should be temporarily discontinued before and after tests using iodinated contrast agents, and resumed only after confirming normal kidney function. Prior to surgery, this medication should be halted for a period, and resumed only after the recovery of kidney function post-surgery. The safety and efficacy of this medication in children under 18 years have not been established, so it is not recommended for this age group. Elderly patients require dosage adjustments and regular monitoring due to the risks of decreased kidney function and fluid loss. In case of overdose, severe side effects such as lactic acidosis may occur, requiring immediate hospital visit, and dialysis may be necessary. This medication should be stored out of reach of children and kept in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 degree and 30 degrees Celsius.
White film-coated tablet with a pink tint, oval and biconvex on both sides
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.